Discover the Benefits of a Subscription

Our content provides subscribers with unique insight and breaking news regarding the most complex mergers and regulatory situations around the world.


The Capitol Forum Advantage

Our work combines cutting edge breaking news with in-depth analysis to better inform readers how policy and regulation affects market competition.

Learn More

The Capitol Forum Community

Our editorial team reconstructs the policy process to yield market insight for a community of subscribers including government regulators, lawyers, investors, and non-profits.

Learn More


View all


View all


We are an investigative news organization providing our subscribers with detail-oriented reporting on antitrust, merger control, corporate investigations, and energy issues.



Barry Nigro - Partner and Antitrust Chair, Fried Frank

"The Capitol Forum’s articles include a good mix of investigative journalism combined with expert analysis and opinion."

Katrina Robson - Partner, Willkie Farr & Gallagher

"Capitol Forum’s comprehensive and diligent reporting on key competitive issues provides helpful insights on and contributes to the vigorous debate around antitrust policy and enforcement."

Mark Ostrau - Partner, Fenwick & West

"I rely on Capitol Forum daily for its valuable combination of timely information and unique insights on key deals and cases. It offers viewpoints and analyses that others don’t, which has become particularly valuable in the current policy environment."

Brendan Coffman - Partner, Wilson Sonsini Goodrich & Rosati

"Capitol Forum is a critical resource because it strikes a unique balance of reporting on breaking stories in antitrust, providing in-depth analysis, and offering a behind the scenes glimpse into the politics and personalities driving modern antitrust enforcement."

Kevin Hahm - Partner, Hunton Andrews Kurth

"I rely on Capitol Forum to get insight and analysis that’s often unavailable from other sources. Their coverage of FTC and DOJ matters is top-notch."

Barry Lynnn - Executive Director, Open Markets Institute

“The Capitol Forum is the only team covering this incredibly important beat. Better yet, their work is deeply intelligent, influential, and almost always right.”

Karl A. Racine - Former D.C. Attorney General

“I appreciate the helpful work done by The Capitol Forum. It’s one of the sources I turn to for information about what activity is out there not only in the antitrust space, but also in the consumer protection world.”

Bert Foer - Former President, American Antitrust Institute

“The Capitol Forum provides an always interesting and sometimes surprising look under the hood about pending antitrust activities.”

Melissa H. Maxman - Partner, Cohen & Gresser

“I have become an avid reader of The Capitol Forum because it provides timely in-depth news and analysis of the myriad legal, business, legislative and political factors affecting business developments. I always come away with fresh perspectives that help me advise my clients about current issues.”

David Witkin - CEO, Beryl Capital Management

“The Capitol Forum has been an indispensable resource for me in analyzing regulatory risk affecting companies in my portfolio or watch list.”

Allen Grunes - Shareholder, Brownstein Hyatt Farber Schreck

“The Capitol Forum consistently provides timely and sophisticated news and analysis of important M & A transactions. It’s the real deal!”

Ted Boettner - Senior Researcher, Ohio River Valley Institute

"Unlike most media outlets, The Capitol Forum digs deep into incredibly complex issues of great importance, providing timely and relevant analysis that you can use to inform your work."


View all


View all

Capitol Forum Overview

Jun 10, 2024

Our content provides subscribers with unique insight and breaking news regarding the most complex mergers and regulatory situations in jurisdictions around the world. Download our PDF here to learn...
Thank you for subscribing to our newsletter


View all

SPECIAL REPORT: Coordination Out Loud

Analysis of select corporate transcripts through the lens of Joseph Harrington’s landmark paper, “Collusion in Plain Sight: Firms’ use of Public Announcements to Restrain Competition.”

Sep 07, 2023 Read Now >

SPECIAL REPORT: Johnson & Johnson’s Remicade

Get an inside view of the biologics market, where rebate schemes appear to drive market share. You’ll learn how a complex system supports sluggish biosimilar uptake and other types of anticompetitive conduct. 

Sep 05, 2023 Read Now >

SPECIAL REPORT: Exclusive Drug Dealing

The Capitol Forum has recently published a special report with an extract of reporting that has been done analyzing price, market share and generic formulary exclusion data to spot anticompetitive conduct.

May 11, 2023 Read Now >